Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis
Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture.We performed a randomized, double-placebo, double-blind clinical trial of 18 months' duration among patients with a rheumatic disease who were starting glucocor...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2006
|
在線閱讀: | https://doi.org/10.1056/nejmoa053569 https://www.nejm.org/doi/pdf/10.1056/NEJMoa053569?articleTools=true |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!